Refining and Testing the Diagnostic Accuracy of PAT-POPS

Pediatric ALL Clinical Trial

Official title:

Refining and Testing the Diagnostic Accuracy of an Assessment Tool (PAT-POPS) to Predict Admission and Discharge of Children and Young People Who Attend an Emergency Department

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT03494998
• Other study ID #: 213469
• Status: Recruiting
• First received: February 26, 2018
• Last updated: April 10, 2018
• Start date: February 8, 2018
• Est. completion date: January 31, 2019

Study information

• Verified date: April 2018
• Source: Pennine Acute Hospitals NHS Trust
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

Increasing attendances by children (aged 0-16 years) at UK emergency departments (EDs) is putting pressure on the National Health Service (NHS). Health professionals make complex judgements on whether children attending EDs can be sent home safely or require admission. The Pennine Acute Hospitals (PAT) Paediatric Observation Priority Score (PAT-POPS) was developed as an ED-specific screening tool for this purpose. A preliminary study showed it to be a potentially effective tool for deciding admission of children from the ED. Therefore, the focus of this study is to refine the original screening tool.

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 80000
• Est. completion date: January 31, 2019
• Est. primary completion date: January 31, 2019
• Gender: All
• Age group: N/A to 16 Years

Eligibility

Inclusion Criteria:

• Children and young people aged 0-16 years of age who attend the Emergency Department

Exclusion Criteria:

• Patients who are confirmed dead on arrival at the Emergency Department

• Patients who attend the Emergency Department in cardio-respiratory arrest

Related Conditions & MeSH terms

• Pediatric ALL

Intervention

Diagnostic Test:
• PAT-POPS
Emergency Department-specific screening tool

Locations

Country	Name	City	State
United Kingdom	Fairfield General Hospital	Bury
United Kingdom	The Royal Oldham Hospital	Oldham
United Kingdom	Rochdale Infirmary	Rochdale

Sponsors (4)

Lead Sponsor	Collaborator
Pennine Acute Hospitals NHS Trust	University Hospitals, Leicester, University of Manchester, University of Salford

Country where clinical trial is conducted

United Kingdom, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Admission or discharge		12 months